Binnacle Investments Inc Lucid Diagnostics Inc. Transaction History
Binnacle Investments Inc
- $137 Billion
- Q1 2025
A detailed history of Binnacle Investments Inc transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Binnacle Investments Inc holds 25 shares of LUCD stock, worth $31. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25Holding current value
$31% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LUCD
# of Institutions
41Shares Held
4.4MCall Options Held
0Put Options Held
0-
Luminus Management LLC Houston, TX1.02MShares$1.26 Million1.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA889KShares$1.1 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny459KShares$569,2400.0% of portfolio
-
Sunbelt Securities, Inc. Houston, TX384KShares$476,1580.06% of portfolio
-
Geode Capital Management, LLC Boston, MA303KShares$375,9370.0% of portfolio
About Lucid Diagnostics Inc.
- Ticker LUCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 38,568,500
- Market Cap $47.8M
- Description
- Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...